

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 9.08147874 |
| 2 | proline metabolic process (GO:0006560) | 7.08026361 |
| 3 | embryonic process involved in female pregnancy (GO:0060136) | 6.40786316 |
| 4 | regulation of integrin activation (GO:0033623) | 5.93249590 |
| 5 | positive regulation of protein homooligomerization (GO:0032464) | 5.69092704 |
| 6 | cellular response to ATP (GO:0071318) | 5.28126214 |
| 7 | transcription from mitochondrial promoter (GO:0006390) | 5.14634073 |
| 8 | regulation of protein homooligomerization (GO:0032462) | 4.79289083 |
| 9 | oxidative demethylation (GO:0070989) | 4.74485160 |
| 10 | establishment of apical/basal cell polarity (GO:0035089) | 4.56940289 |
| 11 | replication fork processing (GO:0031297) | 4.51778003 |
| 12 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.38873665 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 4.35375611 |
| 14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.28234112 |
| 15 | protein retention in ER lumen (GO:0006621) | 4.22342444 |
| 16 | embryonic placenta development (GO:0001892) | 4.15998704 |
| 17 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.99303730 |
| 18 | positive regulation of protein oligomerization (GO:0032461) | 3.88860132 |
| 19 | establishment of monopolar cell polarity (GO:0061162) | 3.77270949 |
| 20 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.77270949 |
| 21 | keratan sulfate catabolic process (GO:0042340) | 3.75240155 |
| 22 | sphingoid metabolic process (GO:0046519) | 3.67044722 |
| 23 | arginine catabolic process (GO:0006527) | 3.60573075 |
| 24 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.57973342 |
| 25 | regulation of podosome assembly (GO:0071801) | 3.57249787 |
| 26 | apoptotic cell clearance (GO:0043277) | 3.57169546 |
| 27 | cellular response to zinc ion (GO:0071294) | 3.55362013 |
| 28 | protein localization to endosome (GO:0036010) | 3.53480420 |
| 29 | glial cell migration (GO:0008347) | 3.45745341 |
| 30 | regulation of mononuclear cell migration (GO:0071675) | 3.42796257 |
| 31 | regulation of macrophage chemotaxis (GO:0010758) | 3.42292708 |
| 32 | indole-containing compound catabolic process (GO:0042436) | 3.40595465 |
| 33 | indolalkylamine catabolic process (GO:0046218) | 3.40595465 |
| 34 | tryptophan catabolic process (GO:0006569) | 3.40595465 |
| 35 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.38294292 |
| 36 | xenobiotic catabolic process (GO:0042178) | 3.37322980 |
| 37 | regulation of translational fidelity (GO:0006450) | 3.35656347 |
| 38 | mitochondrial DNA metabolic process (GO:0032042) | 3.35259956 |
| 39 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.34460554 |
| 40 | alkaloid metabolic process (GO:0009820) | 3.29047037 |
| 41 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.27194956 |
| 42 | protein heterotrimerization (GO:0070208) | 3.25226104 |
| 43 | response to lipoprotein particle (GO:0055094) | 3.25053109 |
| 44 | anatomical structure regression (GO:0060033) | 3.18779386 |
| 45 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.18542980 |
| 46 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.17514077 |
| 47 | negative regulation of cell cycle arrest (GO:0071157) | 3.16967910 |
| 48 | DNA deamination (GO:0045006) | 3.13940664 |
| 49 | intestinal cholesterol absorption (GO:0030299) | 3.13243804 |
| 50 | regulation of protein oligomerization (GO:0032459) | 3.13018902 |
| 51 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.12333663 |
| 52 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.11279018 |
| 53 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.09308846 |
| 54 | sphingosine metabolic process (GO:0006670) | 3.08864141 |
| 55 | convergent extension (GO:0060026) | 3.08281682 |
| 56 | protein targeting to vacuole (GO:0006623) | 3.07466949 |
| 57 | protein targeting to lysosome (GO:0006622) | 3.07466949 |
| 58 | establishment of protein localization to vacuole (GO:0072666) | 3.07466949 |
| 59 | negative regulation of complement activation (GO:0045916) | 3.07218419 |
| 60 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.06444569 |
| 61 | regulation of early endosome to late endosome transport (GO:2000641) | 3.05780109 |
| 62 | negative regulation of cartilage development (GO:0061037) | 3.03904696 |
| 63 | COPII vesicle coating (GO:0048208) | 3.00430664 |
| 64 | regulation of cholesterol homeostasis (GO:2000188) | 2.99868993 |
| 65 | exogenous drug catabolic process (GO:0042738) | 2.98412441 |
| 66 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.96861713 |
| 67 | nitric oxide biosynthetic process (GO:0006809) | 2.95978561 |
| 68 | positive regulation of receptor recycling (GO:0001921) | 2.95549261 |
| 69 | DNA strand renaturation (GO:0000733) | 2.95239021 |
| 70 | apoptotic process involved in morphogenesis (GO:0060561) | 2.95103390 |
| 71 | regulation of response to reactive oxygen species (GO:1901031) | 2.92104980 |
| 72 | drug catabolic process (GO:0042737) | 2.89237075 |
| 73 | cellular zinc ion homeostasis (GO:0006882) | 2.89090037 |
| 74 | hypotonic response (GO:0006971) | 2.86385800 |
| 75 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.85751775 |
| 76 | oligosaccharide catabolic process (GO:0009313) | 2.85224672 |
| 77 | regulation of hippo signaling (GO:0035330) | 2.85100614 |
| 78 | embryonic camera-type eye development (GO:0031076) | 2.83256260 |
| 79 | diol metabolic process (GO:0034311) | 2.82550034 |
| 80 | activation of Rac GTPase activity (GO:0032863) | 2.79204766 |
| 81 | indolalkylamine metabolic process (GO:0006586) | 2.77771569 |
| 82 | negative regulation of protein activation cascade (GO:2000258) | 2.77648596 |
| 83 | low-density lipoprotein particle clearance (GO:0034383) | 2.77618173 |
| 84 | arginine metabolic process (GO:0006525) | 2.77460400 |
| 85 | 4-hydroxyproline metabolic process (GO:0019471) | 2.77430487 |
| 86 | mitotic G1/S transition checkpoint (GO:0044819) | 2.76797761 |
| 87 | negative regulation of Ras GTPase activity (GO:0034261) | 2.76754914 |
| 88 | positive regulation of developmental pigmentation (GO:0048087) | 2.76655468 |
| 89 | signal peptide processing (GO:0006465) | 2.75631185 |
| 90 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.75513700 |
| 91 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.75442233 |
| 92 | COPI coating of Golgi vesicle (GO:0048205) | 2.74513397 |
| 93 | Golgi transport vesicle coating (GO:0048200) | 2.74513397 |
| 94 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.74480129 |
| 95 | mRNA cleavage (GO:0006379) | 2.73591455 |
| 96 | tryptophan metabolic process (GO:0006568) | 2.73210864 |
| 97 | cellular response to lithium ion (GO:0071285) | 2.71505338 |
| 98 | L-ascorbic acid metabolic process (GO:0019852) | 2.69987005 |
| 99 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.68127803 |
| 100 | glandular epithelial cell development (GO:0002068) | 2.67253615 |
| 101 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.65315254 |
| 102 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.63932379 |
| 103 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.63023477 |
| 104 | cellular response to toxic substance (GO:0097237) | 2.62710451 |
| 105 | negative regulation of protein oligomerization (GO:0032460) | 2.62305843 |
| 106 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.60773023 |
| 107 | iron ion import (GO:0097286) | 2.60273273 |
| 108 | N-glycan processing (GO:0006491) | 2.59824778 |
| 109 | embryonic eye morphogenesis (GO:0048048) | 2.59525572 |
| 110 | negative regulation of humoral immune response (GO:0002921) | 2.58762378 |
| 111 | negative regulation of mast cell activation (GO:0033004) | 2.57984396 |
| 112 | peptidyl-proline hydroxylation (GO:0019511) | 2.57556112 |
| 113 | regulation of phospholipase A2 activity (GO:0032429) | 2.55876795 |
| 114 | membrane invagination (GO:0010324) | 2.54907912 |
| 115 | G1 DNA damage checkpoint (GO:0044783) | 2.54467548 |
| 116 | lysosome organization (GO:0007040) | 2.53510127 |
| 117 | lytic vacuole organization (GO:0080171) | 2.53510127 |
| 118 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.52059986 |
| 119 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.51604783 |
| 120 | positive regulation by host of viral transcription (GO:0043923) | 2.50420757 |
| 121 | kynurenine metabolic process (GO:0070189) | 2.50000798 |
| 122 | negative regulation of interleukin-12 production (GO:0032695) | 2.49582359 |
| 123 | regulation of cholesterol storage (GO:0010885) | 2.48499066 |
| 124 | labyrinthine layer development (GO:0060711) | 2.48322396 |
| 125 | positive regulation of T cell apoptotic process (GO:0070234) | 2.47815533 |
| 126 | face development (GO:0060324) | 2.47348482 |
| 127 | aromatic amino acid family catabolic process (GO:0009074) | 2.46808755 |
| 128 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.45968020 |
| 129 | negative regulation of stress fiber assembly (GO:0051497) | 2.45921752 |
| 130 | basement membrane organization (GO:0071711) | 2.45796905 |
| 131 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.44094333 |
| 132 | macroautophagy (GO:0016236) | 2.44017560 |
| 133 | positive regulation of lamellipodium assembly (GO:0010592) | 2.43988479 |
| 134 | peptide catabolic process (GO:0043171) | 2.43345184 |
| 135 | regulation of protein polyubiquitination (GO:1902914) | 2.43004610 |
| 136 | triglyceride homeostasis (GO:0070328) | 2.42696990 |
| 137 | phospholipid translocation (GO:0045332) | 2.41755646 |
| 138 | lipid translocation (GO:0034204) | 2.41755646 |
| 139 | pyrimidine-containing compound salvage (GO:0008655) | 2.38760321 |
| 140 | pyrimidine nucleoside salvage (GO:0043097) | 2.38760321 |
| 141 | intracellular pH reduction (GO:0051452) | 2.37254171 |
| 142 | response to nitrosative stress (GO:0051409) | 2.37159313 |
| 143 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.36810887 |
| 144 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.35865379 |
| 145 | diaphragm development (GO:0060539) | 2.35650140 |
| 146 | type B pancreatic cell proliferation (GO:0044342) | 2.30552797 |
| 147 | establishment of protein localization to Golgi (GO:0072600) | 2.29713361 |
| 148 | cellular ketone body metabolic process (GO:0046950) | 2.29353960 |
| 149 | bile acid biosynthetic process (GO:0006699) | 2.27167383 |
| 150 | negative regulation of protein kinase B signaling (GO:0051898) | 2.26332854 |
| 151 | endosome to melanosome transport (GO:0035646) | 2.25545599 |
| 152 | endosome to pigment granule transport (GO:0043485) | 2.25545599 |
| 153 | pH reduction (GO:0045851) | 2.24071820 |
| 154 | cell adhesion mediated by integrin (GO:0033627) | 2.23827098 |
| 155 | positive regulation of cell size (GO:0045793) | 2.23505004 |
| 156 | benzene-containing compound metabolic process (GO:0042537) | 2.23268664 |
| 157 | amino sugar catabolic process (GO:0046348) | 2.23243460 |
| 158 | prostate gland growth (GO:0060736) | 2.22725998 |
| 159 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.21410025 |
| 160 | glycosphingolipid catabolic process (GO:0046479) | 2.19601079 |
| 161 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.19377355 |
| 162 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.18316249 |
| 163 | glomerular basement membrane development (GO:0032836) | 2.17752040 |
| 164 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.17028785 |
| 165 | negative regulation of vascular permeability (GO:0043116) | 2.16419735 |
| 166 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.16335983 |
| 167 | aromatic amino acid family metabolic process (GO:0009072) | 2.15552494 |
| 168 | negative regulation of lipid storage (GO:0010888) | 2.15238065 |
| 169 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.11912490 |
| 170 | glycolipid catabolic process (GO:0019377) | 2.08306713 |
| 171 | neurotransmitter biosynthetic process (GO:0042136) | 2.06814393 |
| 172 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.04926047 |
| 173 | positive regulation of focal adhesion assembly (GO:0051894) | 2.04214844 |
| 174 | positive regulation of cell junction assembly (GO:1901890) | 2.04214844 |
| 175 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.03813428 |
| 176 | positive regulation of prostaglandin secretion (GO:0032308) | 2.02502935 |
| 177 | cellular response to arsenic-containing substance (GO:0071243) | 2.00932285 |
| 178 | adhesion of symbiont to host cell (GO:0044650) | 2.00407851 |
| 179 | virion attachment to host cell (GO:0019062) | 2.00407851 |
| 180 | ceramide catabolic process (GO:0046514) | 1.99833445 |
| 181 | ketone body metabolic process (GO:1902224) | 1.99700680 |
| 182 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 1.98645052 |
| 183 | blood vessel maturation (GO:0001955) | 1.97355754 |
| 184 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 1.96192256 |
| 185 | nucleoside salvage (GO:0043174) | 1.95625832 |
| 186 | pyridine nucleotide biosynthetic process (GO:0019363) | 1.95333403 |
| 187 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 1.95333403 |
| 188 | positive regulation of icosanoid secretion (GO:0032305) | 1.94910986 |
| 189 | positive regulation of cholesterol transport (GO:0032376) | 1.94903838 |
| 190 | positive regulation of sterol transport (GO:0032373) | 1.94903838 |
| 191 | protein hydroxylation (GO:0018126) | 1.94262730 |
| 192 | positive regulation of vasculogenesis (GO:2001214) | 1.93623997 |
| 193 | lung lobe morphogenesis (GO:0060463) | 1.92482942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.13941383 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.06282165 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.80765510 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.77136671 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.68996745 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.63921971 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44200377 |
| 8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.31100705 |
| 9 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.31100705 |
| 10 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.31100705 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.30063895 |
| 12 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.24905011 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.22214505 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.20078775 |
| 15 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.19961842 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.18658475 |
| 17 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.14219743 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14118708 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.13755797 |
| 20 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.13552329 |
| 21 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.08935392 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.07142186 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.99256983 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99107842 |
| 25 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.97406124 |
| 26 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.96493263 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.96447437 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.92360115 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.92192840 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.91324359 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.84412015 |
| 32 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.82455059 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.80878999 |
| 34 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.80397898 |
| 35 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.80319092 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.80314423 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77035482 |
| 38 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76947871 |
| 39 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.74956901 |
| 40 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.74325642 |
| 41 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.73558464 |
| 42 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.72516079 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72430893 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.67177516 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66554989 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.65640999 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65256801 |
| 48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65131567 |
| 49 | TP53_16413492_ChIP-PET_HCT116_Human | 1.64174756 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62235132 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62081593 |
| 52 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.61773378 |
| 53 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.61007201 |
| 54 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56880272 |
| 55 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.55872450 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55856709 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.55646061 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.55646061 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55589097 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.54288772 |
| 61 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.52794071 |
| 62 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.52275881 |
| 63 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51227546 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50039796 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49834057 |
| 66 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49727849 |
| 67 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.49454747 |
| 68 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.49347026 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48599912 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47994461 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47776673 |
| 72 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.47678458 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46523078 |
| 74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46425469 |
| 75 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.45636630 |
| 76 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44583472 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.43037543 |
| 78 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.42663905 |
| 79 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.42357036 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42155459 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41448255 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41146053 |
| 83 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41015004 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.40812255 |
| 85 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.40103105 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.39369861 |
| 87 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38253842 |
| 88 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.37454767 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36674915 |
| 90 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.36219233 |
| 91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34739309 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33738138 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32465463 |
| 94 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.31867631 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31104660 |
| 96 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30153220 |
| 97 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29855943 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.29648965 |
| 99 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.29595477 |
| 100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.29595477 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29581011 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29248930 |
| 103 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.28942437 |
| 104 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28797169 |
| 105 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.27917164 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27847561 |
| 107 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.26888802 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.25989184 |
| 109 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25890495 |
| 110 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25530229 |
| 111 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25427478 |
| 112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24949939 |
| 113 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24423102 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.23289281 |
| 115 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.23016117 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22953553 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22869385 |
| 118 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.22578268 |
| 119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19110241 |
| 120 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.19058901 |
| 121 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.18538859 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18289665 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18143378 |
| 124 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17889006 |
| 125 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17676749 |
| 126 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16454739 |
| 127 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16259281 |
| 128 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16163842 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.16083649 |
| 130 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16030293 |
| 131 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15152091 |
| 132 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14142221 |
| 133 | MYC_22102868_ChIP-Seq_BL_Human | 1.14009211 |
| 134 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13750099 |
| 135 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12231256 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11920771 |
| 137 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11283697 |
| 138 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.10640840 |
| 139 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.09979444 |
| 140 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.09899345 |
| 141 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.09596938 |
| 142 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.09130670 |
| 143 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08353660 |
| 144 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08102993 |
| 145 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07540033 |
| 146 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.07490968 |
| 147 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07441059 |
| 148 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07198487 |
| 149 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07033627 |
| 150 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.06742077 |
| 151 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06430375 |
| 152 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.06416773 |
| 153 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06055724 |
| 154 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06040662 |
| 155 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05639191 |
| 156 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.04864919 |
| 157 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04726328 |
| 158 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04203009 |
| 159 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04022256 |
| 160 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04001528 |
| 161 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03631998 |
| 162 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03613533 |
| 163 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02923128 |
| 164 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02671475 |
| 165 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02217509 |
| 166 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.01732345 |
| 167 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01673208 |
| 168 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01636959 |
| 169 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00750151 |
| 170 | MAF_26560356_Chip-Seq_TH1_Human | 1.00423032 |
| 171 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00347325 |
| 172 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00288750 |
| 173 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.00252706 |
| 174 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99705587 |
| 175 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.99368329 |
| 176 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98833201 |
| 177 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98632691 |
| 178 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98298210 |
| 179 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98251184 |
| 180 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96957439 |
| 181 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96565497 |
| 182 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96131531 |
| 183 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94768531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.79699606 |
| 2 | MP0009278_abnormal_bone_marrow | 3.70864776 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.58858222 |
| 4 | MP0006054_spinal_hemorrhage | 3.55283130 |
| 5 | MP0005171_absent_coat_pigmentation | 3.03579916 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.91663376 |
| 7 | MP0003646_muscle_fatigue | 2.74670403 |
| 8 | MP0003283_abnormal_digestive_organ | 2.72834807 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.69852651 |
| 10 | MP0005167_abnormal_blood-brain_barrier | 2.64199243 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.56854317 |
| 12 | MP0002009_preneoplasia | 2.47452252 |
| 13 | MP0003950_abnormal_plasma_membrane | 2.39317131 |
| 14 | MP0000383_abnormal_hair_follicle | 2.35339243 |
| 15 | MP0005365_abnormal_bile_salt | 2.33281862 |
| 16 | MP0004043_abnormal_pH_regulation | 2.33126451 |
| 17 | MP0003724_increased_susceptibility_to | 2.22814341 |
| 18 | MP0005076_abnormal_cell_differentiation | 2.15482748 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.13583254 |
| 20 | MP0010030_abnormal_orbit_morphology | 2.12300259 |
| 21 | MP0004233_abnormal_muscle_weight | 2.06465219 |
| 22 | MP0008057_abnormal_DNA_replication | 2.05532941 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 2.01320464 |
| 24 | MP0010678_abnormal_skin_adnexa | 2.01006691 |
| 25 | MP0004272_abnormal_basement_membrane | 1.94842414 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 1.86694227 |
| 27 | MP0003453_abnormal_keratinocyte_physiol | 1.84425094 |
| 28 | MP0010386_abnormal_urinary_bladder | 1.82150192 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.81662691 |
| 30 | MP0002234_abnormal_pharynx_morphology | 1.78342247 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.74606190 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.74606190 |
| 33 | MP0005360_urolithiasis | 1.72473029 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.72314606 |
| 35 | MP0009764_decreased_sensitivity_to | 1.70614263 |
| 36 | MP0009053_abnormal_anal_canal | 1.62300025 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.60235053 |
| 38 | MP0003045_fibrosis | 1.49170219 |
| 39 | MP0002060_abnormal_skin_morphology | 1.49136828 |
| 40 | MP0005275_abnormal_skin_tensile | 1.46285902 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.45374687 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.45170236 |
| 43 | MP0004858_abnormal_nervous_system | 1.44074902 |
| 44 | MP0009840_abnormal_foam_cell | 1.39629570 |
| 45 | MP0003279_aneurysm | 1.39189068 |
| 46 | MP0000538_abnormal_urinary_bladder | 1.38981014 |
| 47 | MP0000427_abnormal_hair_cycle | 1.36656295 |
| 48 | MP0005023_abnormal_wound_healing | 1.36617091 |
| 49 | MP0005508_abnormal_skeleton_morphology | 1.30965379 |
| 50 | MP0004883_abnormal_blood_vessel | 1.30858177 |
| 51 | MP0003252_abnormal_bile_duct | 1.30600974 |
| 52 | MP0001542_abnormal_bone_strength | 1.30109389 |
| 53 | MP0000371_diluted_coat_color | 1.29600588 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.28784524 |
| 55 | MP0005164_abnormal_response_to | 1.28611854 |
| 56 | MP0001756_abnormal_urination | 1.23912040 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.23522117 |
| 58 | MP0000604_amyloidosis | 1.22739162 |
| 59 | MP0000685_abnormal_immune_system | 1.22092142 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.21632169 |
| 61 | MP0003195_calcinosis | 1.20882783 |
| 62 | MP0003075_altered_response_to | 1.20643086 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.17601865 |
| 64 | MP0002282_abnormal_trachea_morphology | 1.17549470 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.14470907 |
| 66 | MP0000467_abnormal_esophagus_morphology | 1.13471156 |
| 67 | MP0001958_emphysema | 1.12295828 |
| 68 | MP0009115_abnormal_fat_cell | 1.11898340 |
| 69 | MP0005503_abnormal_tendon_morphology | 1.11093024 |
| 70 | MP0009384_cardiac_valve_regurgitation | 1.09979300 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 1.09486926 |
| 72 | MP0002168_other_aberrant_phenotype | 1.09270044 |
| 73 | MP0000639_abnormal_adrenal_gland | 1.08740444 |
| 74 | MP0004019_abnormal_vitamin_homeostasis | 1.07574631 |
| 75 | MP0003828_pulmonary_edema | 1.06475385 |
| 76 | MP0000767_abnormal_smooth_muscle | 1.06379652 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 1.06373933 |
| 78 | MP0010307_abnormal_tumor_latency | 1.06235761 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 1.05316179 |
| 80 | MP0005595_abnormal_vascular_smooth | 1.02194803 |
| 81 | MP0003890_abnormal_embryonic-extraembry | 1.01947785 |
| 82 | MP0002006_tumorigenesis | 1.00002033 |
| 83 | MP0003303_peritoneal_inflammation | 0.99939307 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.99708653 |
| 85 | MP0005310_abnormal_salivary_gland | 0.99084359 |
| 86 | MP0003436_decreased_susceptibility_to | 0.98223189 |
| 87 | MP0002419_abnormal_innate_immunity | 0.96998357 |
| 88 | MP0001664_abnormal_digestion | 0.96190954 |
| 89 | MP0001764_abnormal_homeostasis | 0.95720138 |
| 90 | * MP0000609_abnormal_liver_physiology | 0.93638892 |
| 91 | MP0003091_abnormal_cell_migration | 0.92855008 |
| 92 | MP0005390_skeleton_phenotype | 0.92635972 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.91166323 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.90241629 |
| 95 | MP0001661_extended_life_span | 0.89272605 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.89143329 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.88853347 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.88314936 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.87202915 |
| 100 | MP0005332_abnormal_amino_acid | 0.87127443 |
| 101 | MP0002405_respiratory_system_inflammati | 0.85618099 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 0.85118467 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.84978958 |
| 104 | MP0002933_joint_inflammation | 0.84670852 |
| 105 | MP0002086_abnormal_extraembryonic_tissu | 0.84016461 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.84007200 |
| 107 | MP0005083_abnormal_biliary_tract | 0.82667163 |
| 108 | MP0001243_abnormal_dermal_layer | 0.81449469 |
| 109 | MP0000470_abnormal_stomach_morphology | 0.80737502 |
| 110 | MP0000490_abnormal_crypts_of | 0.80005264 |
| 111 | MP0000343_altered_response_to | 0.79723234 |
| 112 | MP0005395_other_phenotype | 0.79616036 |
| 113 | MP0004130_abnormal_muscle_cell | 0.79481985 |
| 114 | MP0002971_abnormal_brown_adipose | 0.79010112 |
| 115 | MP0000598_abnormal_liver_morphology | 0.78974918 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.78773568 |
| 117 | MP0005257_abnormal_intraocular_pressure | 0.78498132 |
| 118 | MP0003878_abnormal_ear_physiology | 0.78476568 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.78476568 |
| 120 | MP0000013_abnormal_adipose_tissue | 0.78372322 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.78107215 |
| 122 | MP0005165_increased_susceptibility_to | 0.77966982 |
| 123 | MP0005623_abnormal_meninges_morphology | 0.77849279 |
| 124 | MP0010329_abnormal_lipoprotein_level | 0.77555615 |
| 125 | MP0002269_muscular_atrophy | 0.76562721 |
| 126 | MP0003448_altered_tumor_morphology | 0.75842230 |
| 127 | MP0000249_abnormal_blood_vessel | 0.75679375 |
| 128 | MP0000579_abnormal_nail_morphology | 0.75575004 |
| 129 | MP0002118_abnormal_lipid_homeostasis | 0.75341570 |
| 130 | MP0005248_abnormal_Harderian_gland | 0.75100644 |
| 131 | MP0002090_abnormal_vision | 0.74823830 |
| 132 | MP0000462_abnormal_digestive_system | 0.74358634 |
| 133 | MP0009785_altered_susceptibility_to | 0.73630957 |
| 134 | MP0003119_abnormal_digestive_system | 0.73209479 |
| 135 | MP0008775_abnormal_heart_ventricle | 0.72780306 |
| 136 | MP0000003_abnormal_adipose_tissue | 0.72629000 |
| 137 | MP0002876_abnormal_thyroid_physiology | 0.72508317 |
| 138 | MP0000858_altered_metastatic_potential | 0.71989589 |
| 139 | MP0004133_heterotaxia | 0.71881662 |
| 140 | MP0002135_abnormal_kidney_morphology | 0.71732678 |
| 141 | MP0001533_abnormal_skeleton_physiology | 0.71676589 |
| 142 | MP0008469_abnormal_protein_level | 0.71100334 |
| 143 | MP0000465_gastrointestinal_hemorrhage | 0.70485954 |
| 144 | * MP0006082_CNS_inflammation | 0.70337430 |
| 145 | MP0005670_abnormal_white_adipose | 0.70049554 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.69729719 |
| 147 | MP0004264_abnormal_extraembryonic_tissu | 0.69584979 |
| 148 | MP0001666_abnormal_nutrient_absorption | 0.69138027 |
| 149 | MP0005666_abnormal_adipose_tissue | 0.69071032 |
| 150 | MP0005375_adipose_tissue_phenotype | 0.67676717 |
| 151 | MP0002254_reproductive_system_inflammat | 0.67169324 |
| 152 | MP0002111_abnormal_tail_morphology | 0.65924894 |
| 153 | MP0005367_renal/urinary_system_phenotyp | 0.63761850 |
| 154 | MP0000516_abnormal_urinary_system | 0.63761850 |
| 155 | MP0001340_abnormal_eyelid_morphology | 0.63642405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.74123440 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.74123440 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.74123440 |
| 4 | Turricephaly (HP:0000262) | 4.54756328 |
| 5 | Alopecia of scalp (HP:0002293) | 4.22521248 |
| 6 | Cerebral aneurysm (HP:0004944) | 4.21808584 |
| 7 | Pustule (HP:0200039) | 4.21727332 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 4.17067184 |
| 9 | Ulnar bowing (HP:0003031) | 4.10971812 |
| 10 | Increased IgM level (HP:0003496) | 3.98195921 |
| 11 | * Mucopolysacchariduria (HP:0008155) | 3.88205638 |
| 12 | * Urinary glycosaminoglycan excretion (HP:0003541) | 3.88205638 |
| 13 | * Dysostosis multiplex (HP:0000943) | 3.83195942 |
| 14 | Myocardial infarction (HP:0001658) | 3.81408409 |
| 15 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.62996264 |
| 16 | * Abnormality of polysaccharide metabolism (HP:0011012) | 3.57389932 |
| 17 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.57389932 |
| 18 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.57389932 |
| 19 | Joint stiffness (HP:0001387) | 3.53882986 |
| 20 | Premature rupture of membranes (HP:0001788) | 3.38475083 |
| 21 | Protrusio acetabuli (HP:0003179) | 3.36525299 |
| 22 | Coronal craniosynostosis (HP:0004440) | 3.30299100 |
| 23 | Abnormal hemoglobin (HP:0011902) | 3.16634147 |
| 24 | Concave nail (HP:0001598) | 3.13889347 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.13227850 |
| 26 | Hypochromic microcytic anemia (HP:0004840) | 3.12281732 |
| 27 | Vertebral compression fractures (HP:0002953) | 3.06561391 |
| 28 | Rib fusion (HP:0000902) | 3.04448653 |
| 29 | Loss of speech (HP:0002371) | 3.01625408 |
| 30 | Polycythemia (HP:0001901) | 2.93944208 |
| 31 | Facial hemangioma (HP:0000329) | 2.83649465 |
| 32 | Vaginal fistula (HP:0004320) | 2.82233415 |
| 33 | Growth hormone excess (HP:0000845) | 2.79973419 |
| 34 | Male infertility (HP:0003251) | 2.76391460 |
| 35 | Sparse lateral eyebrow (HP:0005338) | 2.74137123 |
| 36 | Rectovaginal fistula (HP:0000143) | 2.73244365 |
| 37 | Rectal fistula (HP:0100590) | 2.73244365 |
| 38 | Poikiloderma (HP:0001029) | 2.69152717 |
| 39 | Natal tooth (HP:0000695) | 2.67907425 |
| 40 | Abnormality of the renal cortex (HP:0011035) | 2.67549157 |
| 41 | Annular pancreas (HP:0001734) | 2.62691722 |
| 42 | Short humerus (HP:0005792) | 2.61898185 |
| 43 | Tubulointerstitial fibrosis (HP:0005576) | 2.54388470 |
| 44 | Bowed forearm bones (HP:0003956) | 2.51908357 |
| 45 | Bowing of the arm (HP:0006488) | 2.51908357 |
| 46 | Premature skin wrinkling (HP:0100678) | 2.51380313 |
| 47 | Cervical subluxation (HP:0003308) | 2.50746755 |
| 48 | Albinism (HP:0001022) | 2.48883912 |
| 49 | Pancreatic cysts (HP:0001737) | 2.48845497 |
| 50 | Tubular atrophy (HP:0000092) | 2.44955940 |
| 51 | Ketoacidosis (HP:0001993) | 2.44163301 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.43297294 |
| 53 | Increased cerebral lipofuscin (HP:0011813) | 2.43117306 |
| 54 | Orthostatic hypotension (HP:0001278) | 2.42510428 |
| 55 | Dysautonomia (HP:0002459) | 2.41621008 |
| 56 | Large for gestational age (HP:0001520) | 2.40192216 |
| 57 | Hematochezia (HP:0002573) | 2.38864100 |
| 58 | Generalized amyotrophy (HP:0003700) | 2.37958651 |
| 59 | Intestinal fistula (HP:0100819) | 2.37834000 |
| 60 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36033096 |
| 61 | Osteolytic defects of the hand bones (HP:0009699) | 2.36033096 |
| 62 | Blue sclerae (HP:0000592) | 2.34784772 |
| 63 | Hypokinesia (HP:0002375) | 2.33093428 |
| 64 | Congenital sensorineural hearing impairment (HP:0008527) | 2.32589024 |
| 65 | Atrophic scars (HP:0001075) | 2.30554977 |
| 66 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.30021107 |
| 67 | Hypercortisolism (HP:0001578) | 2.28670642 |
| 68 | Hypochromic anemia (HP:0001931) | 2.27841790 |
| 69 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.26584164 |
| 70 | Prolonged neonatal jaundice (HP:0006579) | 2.25386174 |
| 71 | Lip pit (HP:0100267) | 2.25145623 |
| 72 | Nephritis (HP:0000123) | 2.25031376 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.23866817 |
| 74 | Xanthomatosis (HP:0000991) | 2.20209237 |
| 75 | Ovoid vertebral bodies (HP:0003300) | 2.18054067 |
| 76 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.17679472 |
| 77 | Mitral stenosis (HP:0001718) | 2.17465541 |
| 78 | Complement deficiency (HP:0004431) | 2.15395490 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.13905696 |
| 80 | Abnormality of male internal genitalia (HP:0000022) | 2.13512088 |
| 81 | Diaphragmatic weakness (HP:0009113) | 2.13376214 |
| 82 | Abnormality of complement system (HP:0005339) | 2.12560967 |
| 83 | Hypoplastic ischia (HP:0003175) | 2.11216412 |
| 84 | Tubulointerstitial abnormality (HP:0001969) | 2.10228252 |
| 85 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.10000346 |
| 86 | Tongue fasciculations (HP:0001308) | 2.08155800 |
| 87 | Follicular hyperkeratosis (HP:0007502) | 2.07478827 |
| 88 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.07102575 |
| 89 | Muscle fibrillation (HP:0010546) | 2.05845514 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05316355 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.04977819 |
| 92 | Hydroxyprolinuria (HP:0003080) | 2.04977819 |
| 93 | Axonal loss (HP:0003447) | 2.04537392 |
| 94 | Clumsiness (HP:0002312) | 2.02922465 |
| 95 | Keratoconus (HP:0000563) | 2.02887007 |
| 96 | Increased corneal curvature (HP:0100692) | 2.02887007 |
| 97 | Congenital hip dislocation (HP:0001374) | 2.00816380 |
| 98 | Prostate neoplasm (HP:0100787) | 2.00760533 |
| 99 | Exocrine pancreatic insufficiency (HP:0001738) | 1.99240372 |
| 100 | Spondylolisthesis (HP:0003302) | 1.98400078 |
| 101 | Metaphyseal cupping (HP:0003021) | 1.98251812 |
| 102 | Aneurysm (HP:0002617) | 1.98006450 |
| 103 | Mesangial abnormality (HP:0001966) | 1.95779086 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94889621 |
| 105 | Genu recurvatum (HP:0002816) | 1.93364597 |
| 106 | Abnormality of the ischium (HP:0003174) | 1.92611305 |
| 107 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.92578501 |
| 108 | Aortic aneurysm (HP:0004942) | 1.91379472 |
| 109 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91217228 |
| 110 | Tetraparesis (HP:0002273) | 1.91097762 |
| 111 | Multiple lipomas (HP:0001012) | 1.90852068 |
| 112 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.89947988 |
| 113 | Choanal stenosis (HP:0000452) | 1.89497556 |
| 114 | Hypoplasia of the odontoid process (HP:0003311) | 1.89203177 |
| 115 | Intrahepatic cholestasis (HP:0001406) | 1.88092916 |
| 116 | Renal cortical cysts (HP:0000803) | 1.87964333 |
| 117 | Abnormal glycosylation (HP:0012345) | 1.86970732 |
| 118 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.86970732 |
| 119 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.86970732 |
| 120 | Abnormal protein glycosylation (HP:0012346) | 1.86970732 |
| 121 | Aortic dissection (HP:0002647) | 1.86470292 |
| 122 | Elbow flexion contracture (HP:0002987) | 1.85815807 |
| 123 | Vascular calcification (HP:0004934) | 1.85089749 |
| 124 | Hyperextensible skin (HP:0000974) | 1.83805635 |
| 125 | Short chin (HP:0000331) | 1.83054018 |
| 126 | IgA deficiency (HP:0002720) | 1.82324807 |
| 127 | Bifid uvula (HP:0000193) | 1.80758586 |
| 128 | Ankle contracture (HP:0006466) | 1.79752247 |
| 129 | Abnormal biliary tract physiology (HP:0012439) | 1.79712124 |
| 130 | Bile duct proliferation (HP:0001408) | 1.79712124 |
| 131 | Ketosis (HP:0001946) | 1.79665222 |
| 132 | Progressive visual loss (HP:0000529) | 1.79264019 |
| 133 | Glomerulonephritis (HP:0000099) | 1.78882272 |
| 134 | Retinal atrophy (HP:0001105) | 1.78811611 |
| 135 | Disproportionate short-trunk short stature (HP:0003521) | 1.78687847 |
| 136 | Soft skin (HP:0000977) | 1.78474321 |
| 137 | Poor head control (HP:0002421) | 1.78446655 |
| 138 | Facial diplegia (HP:0001349) | 1.78427845 |
| 139 | Cardiomegaly (HP:0001640) | 1.77677503 |
| 140 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.77666917 |
| 141 | Congenital glaucoma (HP:0001087) | 1.77293866 |
| 142 | Deep venous thrombosis (HP:0002625) | 1.76607595 |
| 143 | Short 5th finger (HP:0009237) | 1.75566197 |
| 144 | Narrow nasal bridge (HP:0000446) | 1.75284437 |
| 145 | Increased mean platelet volume (HP:0011877) | 1.74992579 |
| 146 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.73414674 |
| 147 | Abolished electroretinogram (ERG) (HP:0000550) | 1.72644890 |
| 148 | Aortic valve stenosis (HP:0001650) | 1.72129063 |
| 149 | Glucose intolerance (HP:0000833) | 1.71701935 |
| 150 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71615297 |
| 151 | Opisthotonus (HP:0002179) | 1.71488741 |
| 152 | Amelogenesis imperfecta (HP:0000705) | 1.70992637 |
| 153 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.70768339 |
| 154 | Ectropion (HP:0000656) | 1.70579093 |
| 155 | Facial shape deformation (HP:0011334) | 1.69761764 |
| 156 | Potter facies (HP:0002009) | 1.69761764 |
| 157 | Peritonitis (HP:0002586) | 1.68599744 |
| 158 | Depressed nasal tip (HP:0000437) | 1.67530051 |
| 159 | Severe visual impairment (HP:0001141) | 1.66361734 |
| 160 | Beaking of vertebral bodies (HP:0004568) | 1.66179905 |
| 161 | Popliteal pterygium (HP:0009756) | 1.64961912 |
| 162 | Abnormal glucose tolerance (HP:0001952) | 1.64749875 |
| 163 | Amyloidosis (HP:0011034) | 1.64537790 |
| 164 | Vascular tortuosity (HP:0004948) | 1.63500614 |
| 165 | * Progressive neurologic deterioration (HP:0002344) | 1.61152426 |
| 166 | Abnormality of the pericardium (HP:0001697) | 1.61018774 |
| 167 | Abnormality of macrophages (HP:0004311) | 1.60857796 |
| 168 | Proximal tubulopathy (HP:0000114) | 1.60170228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 6.12098776 |
| 2 | DDR2 | 5.28558340 |
| 3 | ICK | 4.33917414 |
| 4 | MAP3K6 | 3.53040998 |
| 5 | STK24 | 2.93662978 |
| 6 | MAP3K11 | 2.87890231 |
| 7 | STK39 | 2.86485248 |
| 8 | PDGFRA | 2.72582347 |
| 9 | ACVR1B | 2.55210844 |
| 10 | CSK | 2.52955789 |
| 11 | FER | 2.49714097 |
| 12 | TIE1 | 2.47130257 |
| 13 | FGR | 2.42291934 |
| 14 | MATK | 2.37071447 |
| 15 | PIM2 | 2.36879542 |
| 16 | BMX | 2.35659421 |
| 17 | PINK1 | 2.21298840 |
| 18 | ERN1 | 2.20010584 |
| 19 | WNK4 | 2.19823137 |
| 20 | TRIB3 | 2.16266945 |
| 21 | DYRK1B | 2.03469783 |
| 22 | PRKD2 | 1.96735571 |
| 23 | TYRO3 | 1.85910677 |
| 24 | MYLK | 1.83801135 |
| 25 | BMPR1B | 1.83728256 |
| 26 | ADRBK2 | 1.81481572 |
| 27 | GRK1 | 1.77351208 |
| 28 | TRPM7 | 1.74688225 |
| 29 | CCNB1 | 1.55089103 |
| 30 | PIK3CG | 1.48630451 |
| 31 | CDK6 | 1.46187753 |
| 32 | DAPK1 | 1.42724318 |
| 33 | ZAK | 1.41845241 |
| 34 | SIK1 | 1.31416643 |
| 35 | YES1 | 1.29974746 |
| 36 | UHMK1 | 1.27586340 |
| 37 | EPHA2 | 1.24782796 |
| 38 | PIM1 | 1.23707117 |
| 39 | NEK9 | 1.23361044 |
| 40 | GSK3A | 1.21172824 |
| 41 | LATS1 | 1.16699367 |
| 42 | LATS2 | 1.13255940 |
| 43 | TESK1 | 1.12838079 |
| 44 | MUSK | 1.10612429 |
| 45 | ILK | 1.04278067 |
| 46 | PTK2B | 1.00308721 |
| 47 | RPS6KC1 | 0.99953350 |
| 48 | RPS6KL1 | 0.99953350 |
| 49 | MAPK11 | 0.99589442 |
| 50 | LIMK1 | 0.99471390 |
| 51 | HIPK2 | 0.98951642 |
| 52 | RIPK1 | 0.96685496 |
| 53 | MAP4K2 | 0.96569711 |
| 54 | ADRBK1 | 0.95965799 |
| 55 | BMPR2 | 0.95885121 |
| 56 | FLT3 | 0.95702945 |
| 57 | TAOK3 | 0.93814633 |
| 58 | TGFBR2 | 0.93149547 |
| 59 | CDC42BPA | 0.91239802 |
| 60 | TGFBR1 | 0.91017288 |
| 61 | RPS6KA6 | 0.90652504 |
| 62 | GRK7 | 0.88944432 |
| 63 | CSF1R | 0.87793659 |
| 64 | CAMKK2 | 0.86761668 |
| 65 | PRKCE | 0.86375036 |
| 66 | PTK2 | 0.85746621 |
| 67 | EEF2K | 0.84994623 |
| 68 | PDGFRB | 0.82605037 |
| 69 | STK3 | 0.82394013 |
| 70 | CDK7 | 0.80523073 |
| 71 | MAP3K10 | 0.77840425 |
| 72 | SCYL2 | 0.76150662 |
| 73 | MTOR | 0.75772904 |
| 74 | NME2 | 0.74759563 |
| 75 | TBK1 | 0.70049708 |
| 76 | MST1R | 0.69668260 |
| 77 | CSNK1A1L | 0.67732188 |
| 78 | TEC | 0.64447998 |
| 79 | OXSR1 | 0.63438620 |
| 80 | IKBKB | 0.63108013 |
| 81 | MAP2K1 | 0.62897783 |
| 82 | MAP3K3 | 0.62769567 |
| 83 | AKT3 | 0.62677528 |
| 84 | ERBB3 | 0.62472158 |
| 85 | FRK | 0.62233678 |
| 86 | PRKAA1 | 0.62067462 |
| 87 | CSNK1G3 | 0.61721722 |
| 88 | EGFR | 0.61650764 |
| 89 | TYK2 | 0.61045117 |
| 90 | RPS6KA2 | 0.60582954 |
| 91 | PTK6 | 0.57495725 |
| 92 | CHUK | 0.57186106 |
| 93 | MAPKAPK5 | 0.57046366 |
| 94 | PAK2 | 0.56671922 |
| 95 | GRK6 | 0.56257231 |
| 96 | PBK | 0.56147051 |
| 97 | MAP3K12 | 0.54708615 |
| 98 | PRKAA2 | 0.54481227 |
| 99 | JAK2 | 0.54318520 |
| 100 | INSRR | 0.53670708 |
| 101 | TTN | 0.53601773 |
| 102 | PRKCQ | 0.53542982 |
| 103 | IRAK1 | 0.53128647 |
| 104 | MST4 | 0.52485270 |
| 105 | MAPKAPK3 | 0.52381419 |
| 106 | TNK2 | 0.51760255 |
| 107 | TAOK2 | 0.51264010 |
| 108 | CSNK1G1 | 0.50852781 |
| 109 | FGFR4 | 0.49600705 |
| 110 | BCKDK | 0.49543595 |
| 111 | RPS6KA1 | 0.49300820 |
| 112 | PKN2 | 0.49030596 |
| 113 | INSR | 0.47428752 |
| 114 | PHKG1 | 0.46948601 |
| 115 | PHKG2 | 0.46948601 |
| 116 | DMPK | 0.46946835 |
| 117 | LYN | 0.45963720 |
| 118 | JAK1 | 0.45078949 |
| 119 | IKBKE | 0.44887672 |
| 120 | ABL1 | 0.44104406 |
| 121 | STK38L | 0.43841121 |
| 122 | MAP3K14 | 0.42979049 |
| 123 | MAP2K6 | 0.42422376 |
| 124 | CAMK1D | 0.42120967 |
| 125 | PIK3CA | 0.42005255 |
| 126 | CDK12 | 0.40950178 |
| 127 | MAP3K2 | 0.40226466 |
| 128 | IGF1R | 0.39889444 |
| 129 | CAMK4 | 0.39106694 |
| 130 | CAMK1 | 0.39083025 |
| 131 | STK10 | 0.38886116 |
| 132 | EPHA3 | 0.38568820 |
| 133 | IRAK3 | 0.38443866 |
| 134 | MAPKAPK2 | 0.38223066 |
| 135 | HCK | 0.37791978 |
| 136 | NUAK1 | 0.36678563 |
| 137 | JAK3 | 0.36369434 |
| 138 | PRKG2 | 0.35639285 |
| 139 | MET | 0.35279733 |
| 140 | EPHB1 | 0.35172852 |
| 141 | WNK1 | 0.34429452 |
| 142 | MAPK3 | 0.33751836 |
| 143 | BLK | 0.32947967 |
| 144 | PAK4 | 0.32823229 |
| 145 | PRKD1 | 0.32344185 |
| 146 | MAPK1 | 0.32043444 |
| 147 | MAP2K2 | 0.29979832 |
| 148 | MAPK4 | 0.25293650 |
| 149 | NTRK1 | 0.24816572 |
| 150 | PRPF4B | 0.24679146 |
| 151 | ABL2 | 0.24424436 |
| 152 | STK38 | 0.24080977 |
| 153 | LCK | 0.23925077 |
| 154 | ZAP70 | 0.23907257 |
| 155 | RAF1 | 0.23695084 |
| 156 | PRKCD | 0.23294677 |
| 157 | KIT | 0.22958150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.35338026 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.94185001 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.80094669 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30068144 |
| 5 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.14470575 |
| 6 | * Lysosome_Homo sapiens_hsa04142 | 2.09361738 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.97385837 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.96685315 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94347333 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.91672793 |
| 11 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.86691306 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79037054 |
| 13 | Adherens junction_Homo sapiens_hsa04520 | 1.64728170 |
| 14 | Bladder cancer_Homo sapiens_hsa05219 | 1.64625344 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.64550783 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.64526351 |
| 17 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.63693639 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63026138 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59122518 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.57845612 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.57043362 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56630257 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53637999 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.47932909 |
| 25 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.47624485 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.46416125 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.45525645 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.42730157 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.40130963 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.37604634 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36279038 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.36003378 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.34461404 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30141697 |
| 35 | Lysine degradation_Homo sapiens_hsa00310 | 1.27314803 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26790192 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.26017133 |
| 38 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.25462289 |
| 39 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.25338613 |
| 40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.23761662 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22655528 |
| 42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.19278025 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18253977 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.16116729 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16052693 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10906214 |
| 47 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.10379140 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05751996 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05226855 |
| 50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.05041006 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.03783659 |
| 52 | Asthma_Homo sapiens_hsa05310 | 1.03246391 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02738539 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01107690 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00708625 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00510124 |
| 57 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.00445741 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99352779 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99296190 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98117166 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97834054 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.97668955 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97559837 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97229813 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94716844 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.93148766 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92319850 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92069112 |
| 69 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.91017284 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90661385 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.90493810 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90115775 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86958680 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86800058 |
| 75 | Phototransduction_Homo sapiens_hsa04744 | 0.85325378 |
| 76 | Mismatch repair_Homo sapiens_hsa03430 | 0.84249492 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84108392 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82145912 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80423501 |
| 80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80088147 |
| 81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79869502 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79802936 |
| 83 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78227999 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76476201 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73499432 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73045891 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.72331421 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70233498 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70179176 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68367831 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67546643 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67024274 |
| 93 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66838719 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66460561 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66037353 |
| 96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64390490 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64355876 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64324070 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.63857799 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63436934 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63046955 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62037770 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61844028 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61625861 |
| 105 | Allograft rejection_Homo sapiens_hsa05330 | 0.61600277 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61236691 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60806743 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.60427598 |
| 109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60095399 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59842590 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59638855 |
| 112 | Tuberculosis_Homo sapiens_hsa05152 | 0.59510628 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59138073 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59034699 |
| 115 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58873682 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.57506923 |
| 117 | Bile secretion_Homo sapiens_hsa04976 | 0.56711942 |
| 118 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55649346 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.54883040 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54060376 |
| 121 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53340948 |
| 122 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.52761781 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.52423965 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51982260 |
| 125 | Apoptosis_Homo sapiens_hsa04210 | 0.51337243 |
| 126 | Salivary secretion_Homo sapiens_hsa04970 | 0.50790964 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50706328 |
| 128 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50226181 |
| 129 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49713375 |
| 130 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49391978 |
| 131 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48222683 |
| 132 | Peroxisome_Homo sapiens_hsa04146 | 0.47439997 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46795276 |
| 134 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46574219 |
| 135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46399322 |
| 136 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45403836 |
| 137 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44595272 |
| 138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44439227 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44331995 |
| 140 | Hepatitis B_Homo sapiens_hsa05161 | 0.43772795 |
| 141 | Prostate cancer_Homo sapiens_hsa05215 | 0.42977184 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42242182 |
| 143 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41402506 |
| 144 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41381573 |
| 145 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41349415 |
| 146 | Pertussis_Homo sapiens_hsa05133 | 0.38466931 |
| 147 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37247029 |
| 148 | Measles_Homo sapiens_hsa05162 | 0.37228131 |
| 149 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36927881 |
| 150 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34969824 |
| 151 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34596550 |
| 152 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34554564 |
| 153 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34446111 |
| 154 | Hepatitis C_Homo sapiens_hsa05160 | 0.32844351 |
| 155 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.31444545 |
| 156 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30758223 |

